🇺🇸 FDA
Patent

US 9233940

Cyclic peptidomimetic compounds as immunomodulators

granted A61KA61K31/395A61K31/4245

Quick answer

US patent 9233940 (Cyclic peptidomimetic compounds as immunomodulators) held by Aurigene Discovery Technologies Limited expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aurigene Discovery Technologies Limited
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K31/395, A61K31/4245, A61K31/433, A61K45/06